Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Inv. presentation
|
|
SALIX PHARMACEUTICALS LTD (SLXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2015 |
4
| Forbes William P (President, Medical, R&D & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 04/03/2015 |
4
| D ALONZO THOMAS (Acting President and CEO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 04/03/2015 |
4
| CREECH TIMOTHY J (See Remarks) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Unknown transaction of 4,065 shares
@ $173, valued at
$703.2k
Disposed/sold 21,372 shares
@ $173, valued at
$3.7M
|
|
| 04/03/2015 |
4
| KEANE WILLIAM P (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 04/03/2015 |
4
| Bertrand William C JR (See Remarks) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 04/03/2015 |
4
| CHAPPELL JOHN F (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 04/03/2015 |
4
| Sirgo Mark A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Unknown transaction of 31,057 shares
@ $173, valued at
$5.4M
Disposed/sold 6,370 shares
@ $173, valued at
$1.1M
|
|
| 04/01/2015 |
8-K
| Form 8-K - Current report |
| 04/01/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/01/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/25/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/25/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/20/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/18/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/17/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/17/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/16/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/16/2015 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ¨ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ¨ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Item 1.01. Entry into a Material Definitive Agreement. On March 16, 2015, Salix Pharmaceuticals, Ltd., a Delaware corporation , Valeant Pharmaceuticals International, Inc., a British Columbia corporation , Valeant Pharmaceuticals International, a Delaware corporation and a wholly-owned su...",
"Amendment No. 1 to the Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, Sun Merger Sub, Inc. and Salix Pharmaceuticals, Ltd",
"VALEANT AND SALIX AGREE ON AMENDED TERMS TO MERGER AGREEMENT" |
|
| 03/16/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/13/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/13/2015 |
4
| KEANE WILLIAM P (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 03/12/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/12/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/11/2015 |
4
| Forbes William P (President, Medical R&D and CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 03/09/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/09/2015 |
4
| Scruggs Rick D (Executive Vice President) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 03/09/2015 |
4
| Forbes William P (EVP Research&Devel & CDO) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
| 03/09/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/09/2015 |
4
| CREECH TIMOTHY J (See Remarks) has filed a Form 4 on SALIX PHARMACEUTICALS LTD|
Txns:
| Gifted 500 shares
@ $0
Sold 4,600 shares
@ $157.6671, valued at
$725.3k
|
|
| 03/06/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/06/2015 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/04/2015 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 03/02/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
|
|
|